Zynex announces 70% order growth and increases q3 2021 adjusted ebitda estimate

Englewood, colo., oct. 13, 2021 /prnewswire/ -- zynex, inc. (nasdaq: zyxi), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, today announced orders and an increased adjusted ebitda estimate for q3 2021.

ZYXI Ratings Summary

ZYXI Quant Ranking